Header Logo

Connection

Paul Ruff to Doxorubicin

This is a "connection" page, showing publications Paul Ruff has written about Doxorubicin.
Connection Strength

0,163
  1. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol. 2007 Jul 20; 25(21):3069-75.
    View in: PubMed
    Score: 0,072
  2. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells. Anticancer Res. 2002 Jul-Aug; 22(4):2253-9.
    View in: PubMed
    Score: 0,051
  3. Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy. Oncologist. 2019 07; 24(7):933-944.
    View in: PubMed
    Score: 0,040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.